Preoperative Doxorubicin Plus Gyclophosphamide Followed by Preoperative or Postoperative Docetaxel

ONCOLOGY

Volumn 11, Issue 6 SUPPL., 1997, Pages 37-40

  Mamounas, Eleftherios P ^a  

^a Med Oversight Natl Surg AB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; DOCETAXEL; TAMOXIFEN CITRATE;

ADJUVANT CHEMOTHERAPY; ARTICLE; BREAST TUMOR; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MIDDLE AGED; PATHOLOGY; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE CARE; PREOPERATIVE CARE; RANDOMIZED CONTROLLED TRIAL; SEGMENTAL MASTECTOMY; STATISTICS; TIME; ADULT; BREAST BIOPSY; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER SURGERY; DRUG INDUCED DISEASE; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PARTIAL MASTECTOMY; PHASE 3 CLINICAL TRIAL; PREOPERATIVE TREATMENT;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; CYCLOPHOSPHAMIDE; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; POSTOPERATIVE CARE; PREOPERATIVE CARE; TIME FACTORS;

EID: 0030805625     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Early Bteast Cancer Trialists' Collaborative Group: Effect of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333:1444-1455.1995
2. Early Breast Cancer Tnalists' Collaborative Group Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 33 randomised trials involving 31,000 recurrences and 24,000 deaths among 75,000 women. Lancet. 339:1-15, 71-85, 1992.
3. Fisher B, Rockette H, Robidoux A, et al: Effect of preoperative therapy for breast cancer (BC) on local-regional disease: First report of NSABP B-18 (abstract 57). Proc Am Soc Clin Oncol 13.64, 1994.
4. Mamounas E, Fisher B, Rockette H, et al: Clinical and pathologic local-regional response of operable breast cancer (BC) to preoperative chemotherapy: Results from NSABP B-18 (abstract). Society of Surgical Oncolog\Meeting: Atlanta, GA, March 20-24, 1996.
5. Data on file. Rhone-Poulenc Rorer Pharmaceuticals. Inc. Collegeville, PA.
6. Bristol-Myers Squibb Oncology. Taxol (paclitaxel) for injection concentrate prescribing information, in Physicians' Desk Reference, 50th ed, pp 714-717. Montvale, New Jersey, Medical Economics, 1996.
7. Fisher B, Mamounas EP: Preoperative chemotherapy: A model for studying the biology and therapy of primary breast cancer. J Clin Oncol 13:537-540, 1995.